Evaluating the therapeutic efficacy of gastramide theranostics targeting cholecystokinin-2 receptors in a preclinical setting

RSC Advances 2026 Open access

Read full text
Authors: Marwa Nadia Rahimi, Jo‐Anne Pinson, J.P. Hilton-Proctor, Jessica Van Zuylekom, Benjamin J. Blyth, Peter D. Roselt, Mohammad B. Haskali
DOI: 10.1039/d5ra08789a
Cited by: 0
References: 23

Abstract

R-targeted therapy, addressing current limitations and providing an improved treatment option for neuroendocrine tumors with substantially enhanced therapeutic outcomes.

Fields of Study & Subjects

Neuroendocrine Tumor Research Advances Neuropeptides and Animal Physiology Lung Cancer Research Studies

Publication details

Journal / source
RSC Advances
Volume
16
Issue
3
Pages
2123–2132
Publication date
1 January 2026
Language
EN